Evidence map›Paper›PMID 37679348›Full record

ArticleNature communications2023

All-round catalytic and atroposelective strategy via dynamic kinetic resolution for N-/2-/3-arylindoles.

Ahreum Kim, Chanhee Lee, Jayoung Song, Sang Kook Lee, Yongseok Kwon

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Atroposelective catalysis.Nature reviews. Chemistry · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ahreum KimSchool of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Chanhee LeeSchool of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Jayoung SongCollege of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Sang Kook LeeCollege of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.ORCID http://orcid.org/0000-0002-4306-7024
Yongseok KwonSchool of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea. y.kwon@skku.edu.ORCID http://orcid.org/0000-0001-7812-9638
Sungkyunkwan University · KRSeoul National University · KR

Funding

National Research Foundation of Korea (NRF) 2020R1C1C1006231National Research Foundation of Korea (NRF) 2022M3E5F2017857National Research Foundation of Korea (NRF) 2022R1A4A1018930
6 · The paper itself

Abstract

As the complexity of organic molecules utilized by mankind increases, the phenomenon of atropisomerism is more frequently encountered. While a variety of well-established methods enable the control of a stereogenic center, a catalytic method for controlling a stereogenic axis in one substrate is typically unavailable for controlling axial chirality in other substrates with a similar structure. Herein, we report o-amidobiaryl as a flexible platform for chiral phosphoric acid-catalyzed atroposelective dynamic kinetic resolution. To demonstrate our strategy, three distinct types of arylindoles were utilized and reacted intermolecularly with ketomalonate in the presence of chiral phosphoric acid. An investigation of 46 substrates having an aromatic ring in different positions yields the desired products with excellent enantioselectivities. Computational investigation into the origin of enantioselectivity highlights the importance of the NH group. Given the biological significance of indoles, antiproliferative effects have been investigated; our scaffold exhibits good efficacy in this regard.

Identifiers

PMID37679348
PMCPMC10485016
OpenAlexW4386497868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.